A recent study evaluated the role of renal autologous stem cell therapy in managing chronic kidney disease (CKD), a common cause of illness and death in adults with limited treatment options such as medications and kidney replacement therapies. Kidney transplantation is currently the most effective treatment for CKD, but it has drawbacks such as a shortage of suitable donors and various complications. However, recent studies have shown that kidney cells obtained from diseased kidneys can be transformed into fully functional kidney cells, leading to a new treatment option called autologous selected renal cell transplantation. Further large-scale studies involving CKD patients with different causes are necessary to establish the therapeutic potential of autologous selected renal cell transplantation.
Reference: Copur S, Yavuz F, Covic A, Kanbay M. A review on renal autologous cell transplantation: an investigational approach towards chronic kidney disease. Int Urol Nephrol. 2023 Mar 27. doi: 10.1007/s11255-023-03574-5. Epub ahead of print. PMID: 36971874.
READ MORE > https://pubmed.ncbi.nlm.nih.gov/36971874/
